Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01513 LIVZON PHARMA
RT Nominal down38.950 -0.750 (-1.889%)
Ranking Overview
Hold
Ranking based on 1 research report(s)
Average Ranking 3.00
0
0
1
0
0
Previous Financial Performance
Financial Year 12/2024 EPS 224.00 RMB (cts)
Net Profit 2,061.10 RMB (MIL) DPS 110.00 RMB (cts)
Consolidation Estimation
Financial Year Profit / (Loss)
(RMB (MIL))
EPS/
((LPS)(RMB (cts))
DPS
(RMB (cts))
Net Asset Value per Share
(RMB)
Highest
(RMB (MIL))
Lowest
(RMB (MIL))
20252,189.00236.00208.00--2,189.002,189.00
20262,474.00267.00235.00--2,474.002,474.00
20273,003.00324.00285.00--3,003.003,003.00
Profit Estimation
Profit Estimation Profit / (Loss)
(RMB (MIL))
EPS*/
(LPS) (RMB (cts))
DPS *
(RMB (cts))
Broker Ranking Target Price*
(HKD)
Update Date
20252,189.00236.00208.00HSBCHold30.00 09/06/2025
 
20262,474.00267.00235.00HSBC----09/06/2025
 
20273,003.00324.00285.00HSBC----09/06/2025
Remarks:  Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa.
  *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue
  Real time quote last updated: 23/07/2025 13:25
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service